(Q45337198)

English

Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009.

scientific article published on 17 September 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009 (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

cardiovascular disease

1 reference

based on heuristic

inferred from title

Guillaume Paré

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Philip G Joseph

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Stephanie Ross

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Robert Roberts

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Sonia S Anand

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

17 September 2013

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Clinical Cardiology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

37

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

48-56

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Warfarin sensitivity genotyping: a review of the literature and summary of patient experience

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Genetic determinants of response to warfarin during initial anticoagulation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Estimation of the warfarin dose with clinical and pharmacogenetic data

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Pharmacogenetics of oral anticoagulants

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Pharmacogenetics of warfarin

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

CYP4F2 genetic variant alters required warfarin dose

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Effects of CYP2C19 genotype on outcomes of clopidogrel treatment

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Clinical application of cardiovascular pharmacogenetics

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Common variation in the platelet receptor P2RY12 gene is associated with residual on-clopidogrel platelet reactivity in patients undergoing elective percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Terms and conditions: semantic complexity and aspirin resistance

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Aspirin resistance: definition, mechanisms and clinical read-outs

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Pharmacogenetics of aspirin resistance: a comprehensive systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Pharmacogenetic study of statin therapy and cholesterol reduction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Genetic determinants of response to statins

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

An association study of 43 SNPs in 16 candidate genes with atorvastatin response

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Common genetic variation in six lipid-related and statin-related genes, statin use and risk of incident nonfatal myocardial infarction and stroke

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Biological, clinical and population relevance of 95 loci for blood lipids

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

SLCO1B1 variants and statin-induced myopathy--a genomewide study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Cerivastatin, genetic variants, and the risk of rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

The SLCO1B1*5 genetic variant is associated with statin-induced side effects

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Angiotensin-converting enzyme and bradykinin gene polymorphisms and cough: A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

An integrated map of genetic variation from 1,092 human genomes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22200

21 January 2018

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/24105892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24105892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bradykinin B(2) receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough

1 reference

https://pubmed.ncbi.nlm.nih.gov/24105892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/24105892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contemporary management of dyslipidemia in high-risk patients: targets still not met

1 reference

https://pubmed.ncbi.nlm.nih.gov/24105892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of P-glycoprotein on clopidogrel absorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/24105892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant

1 reference

https://pubmed.ncbi.nlm.nih.gov/24105892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variants of ADAMTS1 modify the effectiveness of statins in reducing the risk of myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/24105892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic interactions in the β-adrenoceptor/G-protein signal transduction pathway and survival after coronary artery bypass grafting: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24105892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relevance of P2Y12-receptor gene variation for the outcome of clopidogrel-treated patients undergoing elective coronary stent implantation: A clinical follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/24105892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bedside monitoring to adjust antiplatelet therapy for coronary stenting

1 reference

https://pubmed.ncbi.nlm.nih.gov/24105892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24105892

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CLC.22200

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

release_3mhdsxloajenhkuw2s3dbro7um

1 reference

https://api.fatcat.wiki/v0/release/3mhdsxloajenhkuw2s3dbro7um

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24105892%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45337198&oldid=1844538904"